Numinus Wellness Inc.
NUMIF · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.04 | -0.02 | 0.28 |
| FCF Yield | -185.50% | -44.59% | -35.48% | -11.41% |
| EV / EBITDA | -0.68 | -1.89 | -1.87 | -5.58 |
| Quality | ||||
| ROIC | -424.36% | -126.88% | -55.46% | -24.58% |
| Gross Margin | 27.97% | 36.11% | 27.36% | -5.39% |
| Cash Conversion Ratio | 0.89 | 0.75 | 0.58 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.74% | 148.33% | 94.60% | 141.49% |
| Free Cash Flow Growth | 24.35% | 15.80% | -69.39% | -200.90% |
| Safety | ||||
| Net Debt / EBITDA | -0.01 | 0.05 | 0.90 | 3.81 |
| Interest Coverage | -118.53 | -35.49 | -49.24 | -134.85 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 493.72 |
| Cash Conversion Cycle | -69.21 | -35.18 | -131.09 | -286.37 |